Chapter 37 Osteoporosis in childhood and adolescence.
Nasomyont, N; Gordon, CM.
Marcus and Feldman's Osteoporosis.
2021.
Safety and efficacy of teriparatide treatment for severe osteoporosis in patients with Duchenne muscular dystrophy.
Nasomyont, N; Keefe, C; Tian, C; Hornung, L; Khoury, J; Tilden, JC; Hochwalt, P; Jackson, E; Rybalsky, I; Wong, BL; et al.
Osteoporosis International.
2020;
31:2449-2459.
Intravenous bisphosphonate therapy in children with spinal muscular atrophy.
Nasomyont, N; Hornung, LN; Wasserman, H.
Osteoporosis International.
2020;
31:995-1000.
Central diabetes insipidus in a patient with NFKB2 mutation: Expanding the endocrine phenotype in DAVID syndrome.
Nasomyont, N; Lindsley, AW; Assa'ad, A; Dawson, DB; Neilson, DE; Brady, CC; Rutter, MM.
Journal of Clinical Endocrinology and Metabolism.
2019.
SAT-LB052 Intravenous Bisphosphonate Therapy in Children with Spinal Muscular Atrophy.
Nasomyont, N; Hornung, L; Wasserman, H.
Journal of the Endocrine Society.
2019;
3:sat-lb052.
Growth Hormone Therapy for Turner Syndrome.
Blunden, C; Nasomyont, N; Backeljauw, P.
Pediatric Endocrinology Reviews.
2018;
16:80-90.